Featured News

Securing public and private health insurance coverage of Medical Nutrition Therapy (MNT) for celiac disease patients has been a long-time priority of the Celiac Disease Foundation.

I want to share with you an update of our work in Washington, DC with Congress and NIH to accelerate research for diagnostics, treatments, and a cure for celiac disease.

Thanks to your generous support, we are deploying iCureCeliac and iQualifyCeliac, as well as other assets unique to the Foundation, to further celiac disease drug development.

We are pleased to announce our newest online resource for patients and caregivers to drive policy change to improve the health of those living with celiac disease and accelerate research: iAdvocate.

On Friday, I joined three of the leading celiac disease researchers in the world to present to the NIH’s Autoimmune Disease Coordinating Committee (ADCC) the findings from the CDF-sponsored First SSCD Consensus Workshop: Research Opportunities in Celiac Disease 2020.

We have been hearing from our community about COVID-19 and celiac disease and about our work at the Celiac Disease Foundation during the pandemic. We have answered the most frequently asked questions in a short video for you. 

The Voluntary Recommendations for Managing Celiac Disease in Learning Environments provides definitive guidance for schools, parents and caregivers for 504 accommodations for children with celiac disease. Download the guide and watch the video.

Confronted with the reality of an all-consuming global pandemic, every nonprofit, including the Celiac Disease Foundation, has to figure out where we fit in a world that is quickly changing and into a future that no one can predict.

Last week, one of our 2019 Young Investigator Award recipients, Dr. Benjamin Lebwohl, co-authored a study that showed a small, but statistically significant increase in mortality rates for patients with celiac disease.

Dr. Dan Leffler, Celiac Disease Foundation Medical Advisory Board Member and clinician and researcher at Harvard Medical School and Takeda, spoke about the profound ineffectiveness and failure of the gluten-free diet as a treatment for celiac disease.